These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2400225)
1. Pseudomonas cepacia: a new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom. Simmonds EJ; Conway SP; Ghoneim AT; Ross H; Littlewood JM Arch Dis Child; 1990 Aug; 65(8):874-7. PubMed ID: 2400225 [TBL] [Abstract][Full Text] [Related]
2. Possible nosocomial transmission of Pseudomonas cepacia in patients with cystic fibrosis. Pegues DA; Schidlow DV; Tablan OC; Carson LA; Clark NC; Jarvis WR Arch Pediatr Adolesc Med; 1994 Aug; 148(8):805-12. PubMed ID: 7519103 [TBL] [Abstract][Full Text] [Related]
3. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way? Banerjee D; Stableforth D Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122 [TBL] [Abstract][Full Text] [Related]
4. Nebulised anti-pseudomonal antibiotics for cystic fibrosis. Ryan G; Mukhopadhyay S; Singh M Cochrane Database Syst Rev; 2000; (2):CD001021. PubMed ID: 10796732 [TBL] [Abstract][Full Text] [Related]
5. Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis. Burdge DR; Nakielna EM; Noble MA Infect Control Hosp Epidemiol; 1993 Mar; 14(3):127-30. PubMed ID: 7683031 [TBL] [Abstract][Full Text] [Related]
6. Pseudomonas cepacia: pulmonary infection in patients with cystic fibrosis. Taylor RF; Gaya H; Hodson ME Respir Med; 1993 Apr; 87(3):187-92. PubMed ID: 7684530 [TBL] [Abstract][Full Text] [Related]
7. The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis. Tablan OC; Martone WJ; Jarvis WR Eur J Epidemiol; 1987 Dec; 3(4):336-42. PubMed ID: 3319668 [TBL] [Abstract][Full Text] [Related]
8. Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis. Gladman G; Connor PJ; Williams RF; David TJ Arch Dis Child; 1992 Feb; 67(2):192-5. PubMed ID: 1371914 [TBL] [Abstract][Full Text] [Related]
9. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. Tablan OC; Chorba TL; Schidlow DV; White JW; Hardy KA; Gilligan PH; Morgan WM; Carson LA; Martone WJ; Jason JM J Pediatr; 1985 Sep; 107(3):382-7. PubMed ID: 4032134 [TBL] [Abstract][Full Text] [Related]
10. The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis. Kidd TJ; Soares Magalhães RJ; Paynter S; Bell SC; Lancet Respir Med; 2015 Aug; 3(8):640-50. PubMed ID: 26208994 [TBL] [Abstract][Full Text] [Related]
11. Pseudomonas cepacia in cystic fibrosis patients. Prince A Am Rev Respir Dis; 1986 Oct; 134(4):644-5. PubMed ID: 3094414 [No Abstract] [Full Text] [Related]
19. Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009. Lillquist YP; Cho E; Davidson AG J Cyst Fibros; 2011 May; 10(3):175-80. PubMed ID: 21310671 [TBL] [Abstract][Full Text] [Related]
20. Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates. Tramper-Stranders GA; van der Ent CK; Molin S; Yang L; Hansen SK; Rau MH; Ciofu O; Johansen HK; Wolfs TF Clin Microbiol Infect; 2012 Jun; 18(6):567-74. PubMed ID: 21883670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]